Back to NewEdge Advisors, LLC NewEdge Advisors, LLC

CRBPCRBP

Showing 8 of 14 quarters

Position history for NewEdge Advisors, LLCNewEdge Advisors, LLC's holdings in CORBUS PHARMACEUTICALS HOLDINGS INC

Yes. NewEdge Advisors holds 8 shares of CRBP (Corbus Pharmaceuticals Holdings), worth $75, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. NewEdge Advisors has held CRBP since Q1 2023, across 14 quarterly 13F filings.

Current Value

$75

Current Shares

8

Total Value Change

-$135,589

Total Shares Change

-6,568

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
8
0.0%
$750.0%$9.38
0
2026-Q1
Unchanged
8
0.0%
$750.0%$9.39
0
2025-Q4
Unchanged
8
0.0%
$650.0%$8.14
0
2025-Q3
Unchanged
8
0.0%
$1010.0%$12.65
0
2025-Q2
Decreased
8
-11.1%
$550.0%$6.90
0
2025-Q1
Increased
9
+12.5%
$470.0%$5.31
9
2024-Q4
Decreased
8
-99.9%
$940.0%$11.80
0
2024-Q3
Increased
6,576
+0.1%
$135,6640.0%$20.63
22

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used